Premium
Clinical trial among Scottish children of an anti‐caries dentifrice containing 2% sodium monofluorophosphate
Author(s) -
Hargreaves J. A.,
Chester G. G.
Publication year - 1973
Publication title -
community dentistry and oral epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.061
H-Index - 101
eISSN - 1600-0528
pISSN - 0301-5661
DOI - 10.1111/j.1600-0528.1973.tb01860.x
Subject(s) - dentifrice , medicine , dentistry , clinical trial , clinical study , randomized controlled trial , fluoride , inorganic chemistry , chemistry
– A clinical trial was commenced in 1968 on the Island of Lewis, Scotland, to evaluate the effects of a new dentifrice formulation containing, as its main active ingredient, 2% monofluorophosphate. The trial design conformed to international protocol and three age groups of children, namely, 5‐year‐olds, 8‐year‐olds and 11‐year‐olds, participated for a three‐year period. The results show that the dentifrice is an effective anti‐caries agent and the magnitude of its effects is generally greater than reported in studies of other dentifrice products.